p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab

Mounting evidence supports the role of p53 in metabolic processes involved in breast carcinogenesis. We investigated whether p53 status affects the association of pre-treatment fasting glucose with treatment outcomes in 106 non diabetic, HER2 positive breast cancer patients treated with trastuzumab....

Descripción completa

Detalles Bibliográficos
Autores principales: Vici, Patrizia, Sperati, Francesca, Maugeri-Saccà, Marcello, Melucci, Elisa, Benedetto, Anna Di, Lauro, Luigi Di, Pizzuti, Laura, Sergi, Domenico, Terrenato, Irene, Esposito, Luca, Iannuzzi, Carmelina Antonella, Pasquale, Raffaella, Botti, Claudio, Fuhrman, Barbara, Giordano, Antonio, Mottolese, Marcella, Barba, Maddalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279380/
https://www.ncbi.nlm.nih.gov/pubmed/25071015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279380/
https://www.ncbi.nlm.nih.gov/pubmed/25071015

Ejemplares similares